糖尿病中的纳米遗传学:纳米尺度平台和基因调制的融合,用于代谢重编程
Ruchi Tiwari1, Patibandla Jahnavi2, Gurinderdeep Singh3
1PSIT-Pranveer Singh Institute of Technology (Pharmacy), Kanpur, Uttar Pradesh, India.
Journal of biomaterials science. Polymer edition
|November 26, 2025
概括
纳米遗传学提供了一种精确,持久的方法来为糖尿病重新编程葡萄糖代谢. 这项技术将纳米技术与基因调制相结合,以实现潜在的长期缓解和治愈.
科学领域:
- 生物医学工程 生物医学工程
- 分子生物学分子生物学
- 代谢性疾病研究研究
背景情况:
- 糖尿病是一种全球性健康危机,其标志是β细胞功能障碍,胰岛素耐药性和代谢失调.
- 传统的治疗方法可以控制症状,但不能提供长期的代谢重编程.
- 纳米遗传学成为一种新的策略,用于长期重编程葡萄糖平衡途径.
研究的目的:
- 审查糖尿病纳米基因干预的机制基础.
- 提供纳米平台和基因编辑方式的分类学.
- 从体外模型到临床试验绘制翻译管道,考虑实际挑战.
主要方法:
- 对针对β细胞,肝细胞,脂肪组织和免疫代谢接口的纳米基因干预措施的审查.
- 纳米级载体 (脂质,聚合物,无机,外体,刺激反应) 和基因编辑工具 (RNAi,CRISPR,表观基因编辑,合成基因电路) 的分类.
- 对转化途径,交付,安全,制造和道德考虑的分析,通过多omics和计算建模增强.
主要成果:
- 纳米遗传学为重新编程葡萄糖平衡提供了一种精确而持久的方法.
- 介绍了纳米遗传工具和平台的综合分类.
- 该审查映射了从体外研究到临床应用的进展,突出了关键的挑战和进展.
结论:
- 纳米基因干预对实现糖尿病的长期缓解具有显著的前景.
- 技术创新和翻译突破正在为治愈疗法铺平道路.
- 纳米遗传学的进一步研究和开发可能会彻底改变糖尿病治疗.
相关概念视频
Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are co-secreted in...
Insulin and C-peptide are co-secreted in...
Pathophysiology of Diabetes
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Type I Diabetes II: Pathophysiology
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Diabetic Nephropathy
Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...


